79,546 research outputs found
(Table 2) Concentration of particulate protein in Black Sea waters at Station MUK-1975-30
No full text(Table 2) Concentration of particulate protein in Black Sea waters at Station MUK-1975-3
(Table 1) Concentration of sulfate ion and sulfate/chlorine ratio in waters of the Black Sea
No full text(Table 1) Concentration of sulfate ion and sulfate/chlorine ratio in waters of the Black Se
(Table 1c) Concentration of particulate protein in Black Sea waters at Station ML-1628
No full text(Table 1c) Concentration of particulate protein in Black Sea waters at Station ML-162
(Table 3) Concentration of sulfate and chloride ions and hydrogen sulfide in bottom waters of the Black Sea
No full text(Table 3) Concentration of sulfate and chloride ions and hydrogen sulfide in bottom waters of the Black Se
(Table 2) Concentration of sulfate ion and sulfate-chlorine satio at stations of the permanent section from the Khersones Cape to Bosphorus
No full text(Table 2) Concentration of sulfate ion and sulfate-chlorine satio at stations of the permanent section from the Khersones Cape to Bosphoru
(Table 1b) Concentration of particulate protein in Black Sea waters at Station ML-1626
No full text(Table 1d) Concentration of particulate protein in Black Sea waters at Station ML-162
Results of the Heart Protection Study: Can we still assume a class effect?
No full textStatins share several common features including the mechanism of action, i.e. inhibition of HMG-CoA reductase, as well as LDL-cholesterol (LDL-C) and triglyceride lowering properties. However, statins show minor differences in chemical structure, lipophilicity that could translate into a different pharmacological properties. For example, simvastatin exerted a more favorable effect on HDL-C levels than did atorvastatin when higher doses of the two drugs were compared. Finally, the major considerations to chose between statins for CVD patient therapy include clinical benefits and safety (i.e. evidence-based medicine). Primary prevention trials with pravastatins and lovastatin and secondary prevention trials with pravastatin, fluvastatin and simvastatin have established the clinical benefits of statins. In addition, HPS study was designed to investigate the benefits of simvastatin 40 mg in a broad range of patients at high risk for heart disease including women, the elderly and those with a history of hearth attacks, diabetes, hypertension or vascular disease. The results show the ability of simvastatin to reduce all causes of mortality, vascular death and cardiovascular morbidity. The trial also confirms the safety of simvastatin 40 mg although 60% of patients were receiving additional pharmacological treatment. In summary, it appears that statins are not the same and the choice of the more appropriate statin in high-risk patients should be driven by the evidence-based medicine both in terms of safety and efficacy
A Relational Unsupervised Approach to Author Identification
No full textIn the last decades speaking and writing habits have changed.
Many works faced the author identification task by exploiting frequencybased
approaches, numeric techniques or writing style analysis. Following
the last approach we propose a technique for author identification
based on First-Order Logic. Specifically, we translate the complex data
represented by natural language text to complex (relational) patterns
that represent the writing style of an author. Then, we model an author
as the result of clustering the relational descriptions associated to the
sentences. The underlying idea is that such a model can express the typical
way in which an author composes the sentences in his writings. So,
if we can map such writing habits from the unknown-author model to
the known-author model, we can conclude that the author is the same.
Preliminary results are promising and the approach seems viable in real
contexts since it does not need a training phase and performs well also
with short texts
Variations on the Author
No full text“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Also By The Same Author: AKTiveAuthor, a Citation Graph Approach to Name Disambiguation
No full textThe desire for definitive data and the semantic web drive for inference over heterogeneous data sources requires co-reference resolution to be performed on those data. In particular, name disambiguation is required to allow accurate publication lists, citation counts and impact measures to be determined. This paper describes a graph-based approach to author disambiguation on large-scale citation networks. Using self-citation, co-authorship and document source analyses, AKTiveAuthor clusters papers, achieving precision of 0.997 and recall of 0.818 over a test group of eight surname clusters
- …
